Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore additional resources to study natural toxins, pollutants including PFAS and 6-PPD-Q, and their biological effects.
ENVIRONMENTAL TOXICOLOGY TOOLS & SERVICESKasugamycin is an aminoglycoside that has been found in S. kasugaensis and has diverse biological activities.1,2,3 It is active against S. dysenteriae, S. flexneri, S. sonnei, and S. equi when used at a concentration of 50 mg/ml and B. melitensis at 6.25 mg/ml.1 Kasugamycin (1 kg/ha) reduces the severity of rice sheath blight induced by the plant pathogenic fungi R. solani and C. janseana-induced rice narrow brown leaf spot, as well as increases rice yield.2 It also inhibits acidic mammalian chitinase (CHIA), also known as AMCase, with an IC50 value of 4.13 µM. Kasugamycin (12.5, 25, 50, or 100 mg/kg every other day) decreases lung collagen levels in a mouse model of pulmonary fibrosis induced by the glycopeptide antitumor antibiotic bleomycin (Item No. 13877).3 Formulations containing kasugamycin have been used as fungicides in agriculture.
WARNING This product is not for human or veterinary use.
1. Antimicrobial activity of kasugamycin. J. Antibiot. (Tokyo) 18, 104-106 (1965).
2. Field efficacy of fungicides for management of sheath blight and narrow brown leaf spot of rice. Crop Prot. 104, 72-77 (2018).
3. Kasugamycin is a novel chitinase 1 inhibitor with strong antifibrotic effects on pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 67(3), 309-319 (2022).